In the ever-fluctuating world of penny stock trading, one phenomenon stands out as both captivating and elusive – momentum. It’s a factor where small investments can yield substantial returns, and swift market shifts can lead to incredible opportunities. In this exploration, we dive into the intriguing dynamics of penny stocks driven by momentum, revealing how these low-priced equities can make waves in the investment landscape.
Epazz Going Global with ZenaDrone 1000 Technology
Epazz (OTC:EPAZ): Consumer and commercial drones are becoming increasingly popular as the ultimate solution for aerial photography, exploring rough terrain, and conducting complex operations like those in the military. Likewise, the drone market is growing at a 30% compound annual growth rate and is expected to be worth $190 billion by 2028. The explosive growth presents tremendous opportunities that Epazz is increasingly exploring as it seeks to unlock and maximize shareholders’ value.
While Epazz has made a name for itself as a cloud-based software company that provides customized cloud applications, it’s also a big player in the commercial drone business. Through its wholly-owned subsidiary, ZenaDrone, the company is enhancing intelligent unmanned aerial vehicle technology by incorporating machine learning and artificial intelligence technology.
ZenaDrone 1000 is the company’s flagship drone technology, tailored for industrial and commercial applications. Drone technology stands out by leveraging predictive artificial intelligence analytics and modeling to create predictive models and forecast future outcomes.
The drone has already received positive feedback from various industries, including agriculture, oil and gas, and wildfire management. In addition, it has received military recognition for conducting tests under battlefield conditions.
Consequently, Epazz has started pursuing commercial applications for its ZenaDrone 1000 technology. For instance, it is negotiating with Irish farmers for the provision of precision agriculture drones and government agencies.
The provider of drone technology confirmed the completion of a major presentation with the US Department of Homeland Security on September 7. The department expressed strong interest in using the drone for pilot programs after the presentation. Epazz is also preparing for a series of presentations on drone technology as it secures the necessary certifications and licensing to become a defense contractor.
CEO Shaun Passley, PhD, said, “The demand for ZenaDrone 1000 is high among US government agencies. We will be providing a made-in-America drone that carries a heavy payload at an affordable price.”
The certification push comes as Epazz works on signing pilot programs with the US Air Force after receiving letters of support from the US Navy and the Army.
CEO Shaun Passley, Ph.D., said, “The demand for ZenaDrone 1000 is high among US government agencies. We will be providing a made-in-America drone that carries a heavy payload at an affordable price.”
In addition to pursuing opportunities in the US, Epazz is also expanding its footprint on the global scene with plans to make its drones available in Taiwan. On September 14, the company showcased its ZD1000 drone at the Taiwan US Supply China Business Matchmaking Seminar at the Taipei Aerospace & Defense Technology Exhibition (TADTE) 2023. Consequently, it has established partnerships and supply chain vendors in Taiwan as part of its expansion drive.
Additionally, it is in the process of concluding a Brazilian joint venture to establish a facility and infrastructure for ZenaDrone 1000 operations. On August 24, it confirmed its application to the Brazilian Aviation Authority, paving the way for operational approval. Its ZenaDrone 1000 technology has already captured the interest of over 25 esteemed Brazilian organizations, to the extent of adding a Portuguese language to the ZenaDrone website to ensure seamless communication and accessibility.
Looking For Stocks Ready To Explode? Join Our FREE Newsletter https://capitalgainsreport.com
Enzolytics Inc. (OTC:ENZC): The drug development company is currently committed to the commercialization of its monoclonal antibodies and proprietary proteins for the purpose of treating infectious diseases.
Enzolytics Inc. announced on September 18 that it had inked a business combination agreement for the sale of its subsidiary units, Biogenysis Inc. and Virogenetics Inc., to Sagaliam Acquisition Corp. The transaction would be worth $450,000,000. It was further revealed that the combined entity was expected to be listed on NASDAQ. To that end, the entities had already launched the de-SPAC procedure and would start working on the completion of the project.
Charles Cotropia, Enzolytics’ CEO, said, “We have a well-defined strategy and the necessary technology in place for producing numerous therapeutics for successfully treating numerous viruses that affect patients around the world. Completing the business combination with Sagaliam comes at a critical time. By providing additional funding to biogenysis and virogentics, this combination will make possible the final development of the numerous therapeutics now being produced.”
The transaction could be a significant boon for both operating subsidiaries of Enzolytics. The transaction is expected to open up a number of opportunities for Virogenetics to work on the expansion of its technology and also develop new technology. Additionally, it could also help the company expand its nutraceutical line of products at a much faster rate.
Biogenysis is involved in harnessing the power of advanced artificial intelligence in the realm of drug development and discovery. Its focus is on protecting its assets through tight security with multiple layers and also expanding its intellectual property portfolio by adding artificial intelligence-powered monoclonal antibodies. The artificial intelligence platform that the company deploys has been undergoing constant evolution to take care of the company’s evolving needs.
As a company, Enzolytics has managed to put in place a sound strategy and the necessary technology for producing therapeutics that could treat patients across the world who may have been infected with viruses. The business combination with Sagaliam would provide virogenetics and biogenysis with considerably more funding. In turn, it could lead to the onset of the final development phase of a number of therapeutics that had been under development.
Tego Cyber Inc. (OTC: TGCB): The company is involved in the development of solutions focused on threat intelligence and autonomous threat hunting, as well as correlation.
On September 19, the company announced that it had appointed a new Chief Financial Officer in the form of Robert E. Mikkelsen. The appointment had been made by the company through a business advisory and consulting agreement with Mikkelsen’s firm, Merremia Consulting Inc.
Mikkelse would be the successor to Earl Johnson, who would leave the company in order to take up other opportunities.
Mikkelse would bring diverse experience to Tego Cyber in his role. Over the course of his career, he held positions in finance, accounting, investor relations, and strategic leadership. Over the course of nearly two decades, he had been a C-level executive and business advisor.
“We are pleased to welcome Bobby Mikkelsen to the Tego team,” said Shannon Wilkinson, President and CEO of Tego Cyber Inc.
He had been key to the development of accounting systems and controls for highly sophisticated organizations, fund raising, and mergers and acquisitions. The total value of his fund-raising efforts throughout his career had been pegged at $100 million. He had been awarded his accounting bachelor’s degree from the Eller College of Business at the University of Arizona in 2004. Following his graduation, Mikkelsen went to work for the auditing firm Henry & Lorne LLP. His career in the realm of public accounting saw him work with a large client base, which spanned across companies of different sizes and sectors.
The annual revenues of the companies he worked for went from as low as $100,000 to as much as $1 billion. Some of the sectors he had worked extensively with included technology, health care, and pharmaceuticals. Since October 2018, Mikkelsen has also been the Chief Financial Officer at Item Nine Labs.
Xeriant Inc. (OTC:XERI): Xeriant is a holding company focused on the development, discovery, and commercialization of advanced materials as well as technology for advanced aircraft and spacecraft. The aircraft and spacecraft that Xeriant Inc. is involved with could be commercialized and integrated successfully in a range of industrialized sectors.
The company announced on September 19 that it had published the videos from the test sample production run that had been conducted last week to showcase the fire resistance and strength of Nexboard. NEXBOARD is a green composite, high-performance building panel made mainly from plastic and cellulose-based fiber waste materials like cardboard. The company revealed that the sample boards will be directed at testing agencies for the purpose of independent certifications. Additionally, it would also be marketed to construction companies and home builders who may be interested in moving on to Nexboard.
“We are pleased with last week’s successful production and internal testing of these new NEXBOARD samples and are confident these panels will meet certification requirements and be well-received by the construction industry as they begin to incorporate more sustainable building systems and materials,” commented Keith Duffy, CEO of Xeriant.
In this context, it ought to be noted that the construction and home building industries is now increasingly looking for ‘green’ building materials so as to promote the circular economy. It has also been suggested that the trend will only become more pronounced as more and more viable green products hit the market. Xeriant announced that it had engaged the services of two leading testing agencies last week for the purpose of performing a wide range of physical and mechanical tests of industrial standards.
The video was released by the company on YouTube. One of the videos is related to a five-minute flame test, while the other is a fastener pull-through test. The testing agencies had also informed the company that the certifications would also be awarded in the upcoming weeks.
Disclaimers:CapitalGainsReport (CGR) is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. CapitalGainsReport (CGR) is owned by RazorPitch Inc. and has been retained by Epazz Inc. to assist in the production and distribution of content. ‘CGR’ is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by CapitalGainsReport/RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. CGR/RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Please visit CapitalGainsReport.com/Disclaimer for full disclaimer.